SMR

NuScale Power Corp (SMR) - 2024 Annual Report (10-K) Summary

Business Context and Reporting Period

This summary covers the fiscal year ended December 31, 2024. NuScale Power Corp is a Delaware corporation operating as a holding company for NuScale Power, LLC. The company develops and commercializes Small Modular Reactor (SMR) technology, specifically the NuScale Power Module (NPM). NuScale is the first and only SMR developer to receive a Standard Design Approval (SDA) from the U.S. Nuclear Regulatory Commission (NRC) for a 12-module design. The company is currently transitioning from a research and development phase to commercialization, with its primary near-term project being the Doicesti power plant in Romania in partnership with RoPower Nuclear S.A. and Fluor.

Key Financial Metrics (Year Ended Dec 31, 2024)

Note: The 2024 Net Loss includes a non-cash charge of approximately $223 million related to the change in fair value of warrant liabilities prior to their redemption.

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 62% year-over-year to $37.0 million, driven by engineering and licensing fees for the RoPower project in Romania.
• Cost Optimization: Research and Development (R&D) expenses decreased significantly to $46.8 million from $156.1 million in 2023. This reduction was due to cost optimization measures, a 28% workforce reduction (154 employees), and the absence of the $49.8 million Release Agreement payment made to CFPP LLC in 2023.
• Warrant Redemption: The company redeemed all outstanding warrants in Q4 2024. Prior to redemption, warrant holders exercised 17.9 million warrants, generating $205.4 million in cash proceeds.
• Capital Raising: The company fully utilized a prior "At-The-Market" (ATM) program and initiated a new $200 million ATM program. In 2024, ATM sales and warrant exercises generated approximately $410 million in financing cash flows.
• Liquidity: Cash and cash equivalents increased from $120.3 million in 2023 to $401.6 million in 2024, providing a runway for operations.

Guidance, Outlook, Risks, and Contingencies

• Regulatory Outlook: NuScale expects the NRC to complete its review and grant SDA approval for the 6-module, 77 MWe plant design by mid-year 2025. This approval is critical for expedited licensing by customers.
• Commercialization: The company targets the deployment of NPMs to the RoPower site in Romania as early as 2029, with commercial operation potentially by 2030. No binding contracts for the delivery of NPMs have been signed to date.
• Internal Control Weakness: Management and the independent auditor identified a material weakness in internal control over financial reporting. This relates to insufficient design, implementation, and documentation of IT general controls and financial reporting processes due to a lack of personnel and technical support. The auditor issued an adverse opinion on internal controls.
• Legal Proceedings:
  • Shareholder Class Actions: Consolidated lawsuits allege false/misleading statements regarding customer agreements. A motion to dismiss is pending as of the filing date.
  • SEC Inquiry: The company is cooperating with a voluntary information request from the SEC regarding employment and severance agreements.
  • Resolved Litigation: A lawsuit regarding the Merger Agreement was resolved and dismissed with prejudice in February 2025.
• Future Funding: While current cash reserves are sufficient for the next 12 months, the company expects to require additional funding in future years to support commercialization and R&D.

Key Facts for Investor Verification

• Revenue Concentration: Verify the sustainability of revenue streams, as 11.4% of 2024 revenue came from Fluor (a major shareholder and partner), and the majority of revenue is derived from engineering services rather than product sales.
• Internal Control Remediation: Monitor the company's progress in remediating the material weakness in internal controls, as failure to do so could lead to financial misstatements and loss of investor confidence.
• Regulatory Milestones: Track the NRC's progress on the 6-module SDA application, with an expected approval date of mid-2025. Delays could significantly impact the commercialization timeline.
• Binding Contracts: Confirm the execution of binding EPC and supply contracts with RoPower and Fluor, as the company currently has no binding contracts for NPM delivery.
• Capital Structure: Note the significant dilution potential from the remaining ATM program ($128.8 million capacity) and the exchange of Class B units for Class A shares by legacy equityholders.